Grace Therapeutics, Inc

The current institutional shareholding score of Grace Therapeutics, Inc is 3.00, ranking 192 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 23.76%, representing a quarter-over-quarter decrease of 1.62%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 1.58% of shares outstanding, with 0.23% increase in holdings.